☰

Lisa McKerracher

Affiliations: 
Université de Montréal, Montréal, Canada 
Area:
Ophthalmology, Neuroscience Biology, Molecular Biology
Google:
"Lisa McKerracher"
Mean distance: 17.15
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Samuel David grad student
Richard B. Vallee grad student

Children

Sign in to add trainee
Alyson Fournier grad student 1993-1998
Benjamin Ellezam-St-Denis grad student 2002 Université de Montréal
Pauline Dergham grad student 2004 Université de Montréal
Matthew J. Winton grad student 2004 Université de Montréal

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Woller SA, Ruschel J, Morquette B, et al. (2022) Self-delivering RNAi compounds as therapeutic agents in the central nervous system to enhance axonal regeneration after injury. Iscience. 25: 104379
Fehlings MG, Chen Y, Aarabi B, et al. (2021) A Randomized Controlled Trial of Local Delivery of a Rho-Inhibitor (VX-210) in Patients With Acute Traumatic Cervical Spinal Cord Injury. Journal of Neurotrauma
Fehlings MG, Kim KD, Aarabi B, et al. (2018) Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial. Journal of Neurotrauma
McKerracher L, Rosen KM. (2015) MAG, myelin and overcoming growth inhibition in the CNS. Frontiers in Molecular Neuroscience. 8: 51
McKerracher L, Rosen KM. (2015) MAG, myelin and overcoming growth inhibition in the CNS Frontiers in Molecular Neuroscience. 8
Bond LM, McKerracher L. (2014) Cervical spinal cord injury: tailoring clinical trial endpoints to reflect meaningful functional improvements. Neural Regeneration Research. 9: 1493-7
McKerracher L, Anderson KD. (2013) Analysis of recruitment and outcomes in the phase I/IIa Cethrin clinical trial for acute spinal cord injury. Journal of Neurotrauma. 30: 1795-804
McKerracher L, Guertin P. (2013) Rho as a target to promote repair: translation to clinical studies with cethrin. Current Pharmaceutical Design. 19: 4400-10
McKerracher L, Ferraro GB, Fournier AE. (2012) Rho signaling and axon regeneration. International Review of Neurobiology. 105: 117-40
Fehlings MG, Theodore N, Harrop J, et al. (2011) A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. Journal of Neurotrauma. 28: 787-96
See more...